Publication | Closed Access

MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine

Novel Epigenetic TherapyMedicineCancer GenomicsMir-185 Co-contributeCancer BiologyMicrorna DetectionTumor SuppressorRadiation OncologyOncologyCell BiologyEpigeneticsTumor BiologyOvarian CancerOvarian Cancer Cells